Abstract
The model of the structural complex of cyclophilin B belonging to the immunophilins family with the HIV-1 subtype A V3 loop presenting the principal neutralizing determinant of the virus gp120 envelope protein as well as determinants of cell tropism and syncytium formation was generated by molecular docking methods. Based on the conformational and energy characteristics of the built complex, computer-aided design of the polypeptide able to block effectively the functionally crucial V3 segments was implemented. Analysis of the results obtained in this study and literature data suggests that the generated molecule represents a promising pharmacological substance, which may be used as the basis structure for realization of the protein engineering projects aimed to develop effective drugs for anti-AIDS therapy.
Similar content being viewed by others
References
Hartley, O., Klasse, P.J., Sattentau, Q.J., Moore, J.P., AIDS Res. Hum. Retroviruses, 2005, vol. 21, pp. 171–189.
Sirois, S., Sing, T., and Chou, K.-C., Curr. Protein and Peptide Sci., 2005, vol. 6, pp. 413–422.
Endrich, M.M. and Gehring, H., Eur. J. Biochem., 1998, vol. 252, pp. 441–446.
Barik, S., Cell. Mol. Life. Sci., 2006, vol. 63, pp. 2889–2900.
Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., and Bourne, P.E., Nucleic Acids Research, 2000, vol. 28, pp. 235–242.
Andrianov, A.M., J. Biomol. Struct. Dynam., 2008, vol. 26, pp. 49–56.
Andrianov, A.M., J. Biomol. Struct. Dynam., 2009, vol. 26, pp. 445–454.
Kartikeyan, S., Bharmal, R.N., Tiwari, R.P., and Bisen, P.S., HIV and AIDS: Basic Elements and Priorities, Netherlands: Springer, 2007, p. 428.
Andrianov, A.M. and Anishchenko, I.V., J. Biomol. Struct. Dynam., 2009, vol. 27, pp. 179–194.
Mustard, D. and Ritchie, D.W., Proteins: Struct. Funct. Bioinf., 2005, vol. 60, pp. 269–274.
Berendsen, H. J. C., van der Spoel, D., and van Drunen, R., Comp. Phys. Commun., 1995, vol. 91, pp. 43–56.
Ren, P. and Ponder, J. W., J. Phys. Chem. B, 2003, vol. 107, pp. 5933–5947.
Ablameiko, S.V., Abramov, S.M., Anishchenko, V.V., Medvedev, S.V., Paramonov, N.N., and Chizh, O.R., Konfiguratsii superkomp’yutera SKIF (Configurations of the Supercomputer SKIF), Minsks: United Institute of Informatics Problems, 2005, p. 195.
Smith, L.J., Bolin, K.A., Schwalbe, H., MacArthur, M.W., Thornton, J.M., and Dobson, C.M., J. Mol. Biol., 1996, vol. 255, pp. 494–506.
Hutchinson, E.G. and Thornton, J.M., Protein Sci., 1996, vol. 5, pp. 212–220.
Cormier, E.G. and Dragic, T., J. Virol., 2002, vol. 76, pp. 8953–8957.
LaRosa, G.J., Davide, J.P., Weinhold, K., Waterbury, J.A., Profy, A.T., Lewis, J.A., Langlois, A.J., Dressman, G.R., Boswell, R.N., Shadduk, P., Holley, L.H., Karplus, M., Bolognesi, D.P., Matthews, T.J., Emini, E.A., and Putney, S.D., Science, 1990, vol. 249, pp. 932–935.
Ivanoff, L.A., Looney, D.J., McDanal, C., Morris, J.F., Wong-Staat, F., Lang, A.J., Petteway, S.R., Jr., and Matthews, T.J., (1991) AIDS Res. Hum. Retroviruses, 1991, vol. 7, pp. 595–603.
Minder, D., Boni, J., Schupbach, J., and Gering, H., Arch. Virol., 2002, vol. 147, pp. 1531–1542.
De Jong, J.J., De Ronde, A., Keulen, W., Tersmette, M., and Goudsmit, J., J. Virol., 1992, vol. 66, pp. 6777–6780.
Hu, Q., Napier, K.B., Trent, J.O., Wang, Z., Taylor, S., Griffin, G.E., Peiper, S.C., and Shattock, R.J., J. Mol. Biol., 2005, vol. 350, pp. 699–712.
Ogert, R.A., Lee, M.K., Ross, W., Buckler-White, A., Martin, M.A., and Cho, M.W., J. Virol., 2001, vol. 75, pp. 5998–6006.
Smith, J.A. and Pease, L.J., CRC Crit. Rev. Biochem., 1980, vol. 8, pp. 315–399.
Rose, G.D., Gierasch, L.M., and Smith, J.A., Adv. Prot. Chem., 1985, vol. 37, pp. 1–109.
Newton, A.C., Chem. Rev., 2001, vol. 101, pp. 2353–2364.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.M. Andrianov, I.V. Anishchenko, 2010, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Andrianov, A.M., Anishchenko, I.V. Computer modeling of promising inhibitors of the HIV-1 subtype A replication as a framework for the rational anti-AIDS drug design. Biochem. Moscow Suppl. Ser. B 4, 333–341 (2010). https://doi.org/10.1134/S1990750810040037
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750810040037